CDX2 and colorectal carcinoma: For instance, caudal type homeobox 2 (CDX2) has been firmly established as a diagnostic biomarker for CRC, and the loss of CDX2 has emerged as an independent adverse prognostic factor associated with molecular features of the serrated pathway involving promoter methylation and histone deacetylation [16].